MedTrace Logo

RetroMASTER - Retrospective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes

NCT02109978 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 562

Last updated 2018-06-21

No results posted yet for this study

Summary

This study will examine extreme responders to second- and third-line Type 2 Diabetes (T2D) therapy using a retrospective approach and patients with slow or fast diabetes progression.

Conditions

Sponsors & Collaborators

  • University of Exeter

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • University of Dundee

    collaborator OTHER

  • NHS Tayside

    collaborator OTHER_GOV

  • Royal Devon and Exeter NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Andrew T Hattersley, FRCP, DM, BM · University of Exeter

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02109978 on ClinicalTrials.gov